Original Article

Daily Interferon Monotherapy for Chronic Hepatitis C in Patients with Normal or Near-normal Serum Alanine Transaminase Levels: A Comparison of Two Protocols

Objectives: Up to 30% of the 5 million patients with chronic hepatitis C in the United States have normal serum alanine transaminase (ALT) levels. These individuals have not been treated aggressively, and reported response rates have been low. No study has targeted patients treated in a community practice setting. Methods:…